Suppr超能文献

由鸟苷合成3'-氨基-3'-脱氧鸟苷及3'-氨基-3'-脱氧木糖鸟苷单磷酸酯HepDirect前药

Synthesis of 3'-amino-3'-deoxyguanosine and 3'-amino-3'-deoxyxyloguanosine monophosphate HepDirect prodrugs from guanosine.

作者信息

Bookser Brett C, Raffaele Nicholas B, Reddy K Raja, Fan Kevin, Huang Wenjian, Erion Mark D

机构信息

Metabasis Therapeutics, Inc., La Jolla, California, USA.

出版信息

Nucleosides Nucleotides Nucleic Acids. 2009 Oct;28(10):969-86. doi: 10.1080/15257770903307151.

Abstract

The synthesis of 3'-amino-3'-deoxyguanosine and 3'-amino-3'-deoxyxyloguanosine monophosphate HepDirect prodrugs from guanosine is reported. Initial incorporation of N,N-dibenzylformamidino protection of the C2-amino of guanosine masked the reactivity of that group and simplified purification of subsequent analogues. The first key intermediate, 9-(2,5-bis-O-tert-butyldimethylsilyl-beta-D-ribofuranosyl)-2-N-(N,N-dibenzylformamidino)guanine (3a), was prepared in 60% yield after recycling of the undesired 3',5'-bis-O-protected byproduct (4a) by simple equilibration in methanol to a mixture of the two bis-O-protected compounds. Thus, protected, the 3'-position was manipulated to form the 3'-deoxyribo- or 3'-deoxyxylo-3'-azido derivatives (9 or 16, respectively). Further selective manipulations provided the cis-5'-monophosphate (3-chlorophenyl)-1,3-propanyl diester prodrugs (HepDirect prodrugs), 15 and 21. These HepDirect prodrugs were demonstrated to activate to their respective NTPs in rat hepatocytes.

摘要

报道了从鸟苷合成3'-氨基-3'-脱氧鸟苷和3'-氨基-3'-脱氧木糖鸟苷单磷酸酯HepDirect前药的方法。鸟苷C2-氨基的N,N-二苄基甲脒基保护的初步引入掩盖了该基团的反应性,并简化了后续类似物的纯化过程。第一个关键中间体9-(2,5-双-O-叔丁基二甲基甲硅烷基-β-D-呋喃核糖基)-2-N-(N,N-二苄基甲脒基)鸟嘌呤(3a),在将不需要的3',5'-双-O-保护的副产物(4a)通过在甲醇中简单平衡为两种双-O-保护化合物的混合物进行循环后,以60%的产率制备得到。如此保护后,对3'-位进行操作以形成3'-脱氧核糖基或3'-脱氧木糖基-3'-叠氮基衍生物(分别为9或16)。进一步的选择性操作得到了顺式-5'-单磷酸酯(3-氯苯基)-1,3-丙二醇二酯前药(HepDirect前药)15和21。这些HepDirect前药在大鼠肝细胞中被证明可激活为各自的NTP。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验